X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs ELDER PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES ELDER PHARMA JUBILANT LIFE SCIENCES/
ELDER PHARMA
 
P/E (TTM) x 17.2 -0.2 - View Chart
P/BV x 4.5 0.1 4,479.7% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   ELDER PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
ELDER PHARMA
Jun-14
JUBILANT LIFE SCIENCES/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs187380 49.2%   
Low Rs65188 34.6%   
Sales per share (Unadj.) Rs364.3491.2 74.2%  
Earnings per share (Unadj.) Rs6.8-3.2 -215.2%  
Cash flow per share (Unadj.) Rs24.514.4 170.0%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.9376.5 43.8%  
Shares outstanding (eoy) m159.2820.54 775.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.6 59.8%   
Avg P/E ratio x18.4-89.3 -20.6%  
P/CF ratio (eoy) x5.119.7 26.1%  
Price / Book Value ratio x0.80.8 101.3%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,0615,833 343.9%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0522,179 507.2%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,03410,089 575.2%  
Other income Rs m191257 74.3%   
Total revenues Rs m58,22410,346 562.8%   
Gross profit Rs m5,786-792 -730.7%  
Depreciation Rs m2,812361 778.2%   
Interest Rs m3,2372,756 117.4%   
Profit before tax Rs m-72-3,653 2.0%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1453,713 57.8%   
Tax Rs m696125 556.5%   
Profit after tax Rs m1,090-65 -1,668.6%  
Gross profit margin %10.0-7.8 -127.0%  
Effective tax rate %-965.9-3.4 28,192.3%   
Net profit margin %1.9-0.6 -290.1%  
BALANCE SHEET DATA
Current assets Rs m29,2809,240 316.9%   
Current liabilities Rs m38,9129,998 389.2%   
Net working cap to sales %-16.6-7.5 221.0%  
Current ratio x0.80.9 81.4%  
Inventory Days Days8446 182.2%  
Debtors Days Days5160 84.6%  
Net fixed assets Rs m55,71210,124 550.3%   
Share capital Rs m155206 75.1%   
"Free" reserves Rs m20,9685,582 375.6%   
Net worth Rs m26,2657,734 339.6%   
Long term debt Rs m17,1694,889 351.2%   
Total assets Rs m88,60622,882 387.2%  
Interest coverage x1.0-0.3 -300.6%   
Debt to equity ratio x0.70.6 103.4%  
Sales to assets ratio x0.70.4 148.5%   
Return on assets %4.911.8 41.5%  
Return on equity %4.2-0.8 -491.3%  
Return on capital %11.622.3 51.8%  
Exports to sales %37.83.0 1,243.6%   
Imports to sales %16.50.4 3,859.1%   
Exports (fob) Rs m21,933307 7,153.5%   
Imports (cif) Rs m9,56743 22,197.9%   
Fx inflow Rs m22,004307 7,176.8%   
Fx outflow Rs m11,749125 9,376.6%   
Net fx Rs m10,255181 5,656.5%   
CASH FLOW
From Operations Rs m8,02611,754 68.3%  
From Investments Rs m-1,744-561 311.2%  
From Financial Activity Rs m-4,447-6,762 65.8%  
Net Cashflow Rs m1,8344,432 41.4%  

Share Holding

Indian Promoters % 45.6 39.6 115.2%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 7.5 116.0%  
FIIs % 21.2 16.8 126.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 36.1 58.4%  
Shareholders   23,815 16,479 144.5%  
Pledged promoter(s) holding % 15.9 77.6 20.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   CIPLA  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  SANOFI INDIA  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY18); Net Profit Up 1.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 1.4% YoY). Sales on the other hand came in at Rs 23 bn (up 37.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Sep 19, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - PIRAMAL ENTERPRISES COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS